Sugiya, Ryuji http://orcid.org/0000-0003-2874-0759
Higashimoto, Yuji
Shiraishi, Masashi
Tamura, Tomomi
Kimura, Tamotsu
Chiba, Yasutaka
Nishiyama, Osamu
Arizono, Shinichi
Fukuda, Kanji
Tohda, Yuji
Article History
Received: 6 November 2020
Accepted: 6 May 2021
First Online: 26 May 2021
Declarations
:
: Dr. Tohda Y. has reported personal fees from Kyorin Pharmaceutical, Co., Ltd., Teijin Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Boehringer Ingelheim Co., Ltd., Daiichi Sankyo Co., Ltd., and Astellas, Pearl Therapeutics, Inc., outside the submitted work. The other authors report no conflicts of interest.
Free to read: This content has been made available to all.